Previous clinical studies using L-Carnitine supplementation have noted improvements in some cardiovascular risk factors (such as LDL, total cholesterol, and blood pressure).[3,4,5,8] Supplementation with L-Carnitine has also been found to improve feelings of hunger and fatigue induced by fasting in individuals with metabolic syndrome.[6] And, a 2020 systematic review and meta-analysis of 37 randomized controlled clinical trials found that: l-carnitine supplementation provides a modest reducing effect on body weight, BMI and fat mass, especially among adults with overweight/obesity. [7] It should be noted, though, that a previous 2014 meta-analysis found no benefit from L-carnitine supplementation in patients with cardiovascular disease.[14] Carnitine, Heart Disease & TMAO To further muddy the waters, other research notes an association between carnitine intake and increased plasma levels of pro-atherogenic trimethylamine N-oxide (TMAO).[9,10,16] TMAO has been identified as a risk factor for cardiovascular diseases and reported to be elevated in several cardiovascular events as well as type 2 diabetes
Thylakoid membrane-bound ascorbate peroxidase is a limiting factor of antioxidant systems under photo-oxidative stress
BBA-Proteins Proteom 1854:166177 Smeets K, Cuypers A, Lambrechts A, Semane B, Hoet P, Van Laere A, Vangronsveld J (2005) Induction of oxidative stress and antioxidative mechanisms in Phaseolus vulgaris after Cd application
Chng s hp tc vi cc cht chng oxy ha khc hn ch cng thng oxy ha
Glossary T2DM type 2 diabetes mellitus AMPK AMP-activated protein kinase LKB1 liver kinase B1 ETC electron transport chain mTOR mammalian of mechanistic target of rapamycin TFEB Transcription Factor EB eNOS endothelial nitric oxide synthase PEN2 presenilin enhancer 2 mGPD2 mitochondrial glycerol-3-phosphate dehydrogenase G3P glycerol-3-phosphate DHAP dihydroxyacetone phosphate ULK unc-51 like autophagy activating kinase LV left ventricle LVEF Left Ventricular Ejection Fraction CAD coronary artery disease AMI acute myocardial infarction STEMI ST-Elevation Myocardial Infarction I/R ischemia-reperfusion NLRP3 NLR Family Pyrin Domain Containing 3 ROS reactive oxygen species mPTP mitochondrial permeability transition pore LPS Lipopolysaccharide MMP matrix metalloproteinase TIMP-1 Tissue Inhibitor of Metalloproteinases-1 HF Heart failure DCM Diabetic cardiomyopathy LDH lactate dehydrogenase PPAR peroxisome-proliferator-activated receptor PGC-1 PPAR co-activator-1 GDF-15 growth differentiation factor 15 PK2 Prokineticin 2 PKR1/2 prokineticin receptor1/2 GSK3B Glycogen synthase kinase-3 beta TNF- Tumor Necrosis Factor alpha CRP C-reactive protein DOX doxorubicin IL-6 Interleukin 6 PINK1 phosphatase and tensin homolog (PTEN)induced putative kinase 1 Mfn1/2 Mitofusins1/2 GLP-1 glucagon-like peptide-1 SGLT1 sodium-glucose cotransporter 1 RCT Randomized Controlled Trial References 1 AguilarD.ChanW.BozkurtB.RamasubbuK.DeswalA
